newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference

LONDON, March 08, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced its participation in the 32nd Annual Oppenheimer